Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/03/167
Active ingredient: H-Tyrosine-Glycine-Phenylalanine-Glycine-Glycine-OH
Indication: Treatment of chronic idiopathic myelofibrosis
Sponsor: Abiogen Pharma S.p.A.
Via Meucci 36, 56014 Ospedaletto Pisa, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/10/2003 Orphan designation EMEA/OD/035/03 (2003)3965 of 20/10/2003
03/03/2009 Removal of orphan designation from Community Register